GSK rules out HIV spinout as generics hit results By: CNBC.com News May 06, 2015 at 07:22 AM EDT GlaxoSmithKline looks set to continue its earnings slide in 2015, as generic competition continues to hit sales of asthma treatment Advair. Read More >> Related Stocks: Gsk Plc ADR Novartis Ag ADR